Sorrento Therapeutics, Inc.
SRNE · OTC
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $24 | $37 | $56 | $23 |
| Short-Term Investments | $26 | $90 | $0 | $0 |
| Receivables | $24 | $19 | $16 | $15 |
| Inventory | $10 | $8 | $2 | $3 |
| Other Curr. Assets | $12 | $19 | $12 | $27 |
| Total Curr. Assets | $96 | $173 | $86 | $68 |
| Property Plant & Equip (Net) | $138 | $126 | $74 | $76 |
| Goodwill | $80 | $80 | $44 | $38 |
| Intangibles | $137 | $260 | $74 | $63 |
| Long-Term Investments | $17 | $51 | $256 | $262 |
| Tax Assets | $0 | $78 | $63 | $60 |
| Other NC Assets | $4 | -$73 | -$61 | -$10 |
| Total NC Assets | $376 | $522 | $450 | $490 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $473 | $695 | $536 | $558 |
| Liabilities | – | – | – | – |
| Payables | $48 | $27 | $25 | $28 |
| Short-Term Debt | $30 | $44 | $27 | $43 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $1 | $1 | $4 | $4 |
| Other Curr. Liab. | $250 | $67 | $40 | $41 |
| Total Curr. Liab. | $328 | $139 | $96 | $115 |
| LT Debt | $104 | $194 | $143 | $251 |
| Deferred Rev, NC | $7 | $119 | $113 | $114 |
| Deferred Tax Liab, NC | $1 | $2 | $7 | $9 |
| Other NC Liab. | $55 | $162 | $36 | $35 |
| Total NC Liab. | $167 | $477 | $299 | $410 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $99 | $95 | $54 | $55 |
| Total Liabilities | $495 | $617 | $395 | $525 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$1,959 | -$1,387 | -$958 | -$660 |
| AOCI | $2 | $1 | $1 | -$0 |
| Other Equity | $1,939 | $1,464 | $1,123 | $739 |
| Total Equity | -$19 | $79 | $165 | $79 |
| Supplemental Information | – | – | – | – |
| Minority Interest | -$3 | -$1 | -$24 | -$46 |
| Total Liab. & Tot. Equity | $473 | $695 | $536 | $558 |
| Net Debt | $111 | $201 | $113 | $272 |